These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1078 related articles for article (PubMed ID: 8923833)

  • 1. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL; Irvine CH
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin secretory dynamics in humans under low glucocorticoid feedback.
    Veldhuis JD; Iranmanesh A; Naftolowitz D; Tatham N; Cassidy F; Carroll BJ
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5554-63. PubMed ID: 11701735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
    Bierwolf C; Burgemeister A; Lüthke K; Born J; Fehm HL
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1151-7. PubMed ID: 9543132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; Broglio F; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2611-5. PubMed ID: 10443648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
    Alexander SL; Irvine CH; Donald RA
    Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
    Perini GI; Devinsky O; Hauser P; Gallucci WT; Theodore WH; Chrousos GP; Gold PW; Kling MA
    J Clin Endocrinol Metab; 1992 Feb; 74(2):406-12. PubMed ID: 1309836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free fatty acids exert an inhibitory effect on adrenocorticotropin and cortisol secretion in humans.
    Lanfranco F; Giordano R; Pellegrino M; Gianotti L; Ramunni J; Picu A; Baldi M; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1385-90. PubMed ID: 15001638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.
    Rittmaster RS; Cutler GB; Sobel DO; Goldstein DS; Koppelman MC; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1985 May; 60(5):891-5. PubMed ID: 2984235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL; Irvine CH; Livesey JH; Donald RA
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    Berardelli R; Karamouzis I; Marinazzo E; Prats E; Picu A; Giordano R; Ghigo E; Arvat E
    Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.